Información del producto
Nombre:
Lexibulin
Descripción:
Lexibulin is a drug that is used to treat solid tumours, such as carcinoid syndrome and other types of cancer. It has been shown to suppress the production of pro-inflammatory cytokines in human cells, including IL-6 and TNF-α. Lexibulin can also be used to treat autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. This drug binds to a receptor on the surface of cancer cells called CXCR4. When lexibulin binds to this receptor, it triggers apoptosis or cell death by activating an intracellular signalling pathway called autophagy. Lexibulin also inhibits the proliferation of HL60 leukemia cells by inhibiting their autophagy response.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
434.53 g/mol
Fórmula:
C24H30N6O2
Pureza:
Min. 95%
Color/Forma:
White/Off-White Solid
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
